CME Group Inc. $CME Shares Acquired by Corient Private Wealth LP

Corient Private Wealth LP increased its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 66.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 262,371 shares of the financial services provider's stock after purchasing an additional 104,730 shares during the period. Corient Private Wealth LP owned 0.07% of CME Group worth $57,940,000 at the end of the most recent quarter.

• Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit

A number of other institutional investors have also recently added to or reduced their stakes in the company. Northwestern Mutual Investment Management Company LLC increased its position in shares of CME Group by 0.3% during the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider's stock valued at $3,147,000 after purchasing an additional 37 shares during the period. Rehmann Capital Advisory Group lifted its holdings in shares of CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider's stock valued at $243,000 after buying an additional 37 shares during the period. Endowment Wealth Management Inc. lifted its holdings in shares of CME Group by 4.4% in the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider's stock valued at $244,000 after buying an additional 38 shares during the period. NBT Bank N A NY boosted its stake in CME Group by 2.3% during the first quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider's stock valued at $492,000 after buying an additional 38 shares in the last quarter. Finally, Resonant Capital Advisors LLC grew its holdings in CME Group by 3.8% during the first quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider's stock worth $317,000 after acquiring an additional 39 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CME has been the topic of several research reports. The Goldman Sachs Group dropped their price target on shares of CME Group from $267.00 to $245.00 and set a "sell" rating on the stock in a research report on Tuesday, June 30th. Barclays reduced their price objective on shares of CME Group from $316.00 to $270.00 and set an "equal weight" rating for the company in a research report on Thursday, July 9th. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $249.00 to $250.00 and gave the stock an "underweight" rating in a report on Thursday, July 23rd. Keefe, Bruyette & Woods upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 target price for the company in a report on Thursday, June 18th. Finally, Wall Street Zen upgraded shares of CME Group from a "strong sell" rating to a "sell" rating in a research report on Saturday, August 29th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $289.75.

• Higher-for-Longer Rates Could Reward These 3 Overlooked Stocks

Check Out Our Latest Research Report on CME

Insider Buying and Selling

In other news, Director William R. Shepard acquired 325 shares of the stock in a transaction on Thursday, June 25th. The shares were purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Terrence A. Duffy sold 15,000 shares of the business's stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $274.44, for a total transaction of $4,116,600.00. Following the sale, the chief executive officer directly owned 40,630 shares in the company, valued at approximately $11,150,497.20. This trade represents a 26.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is owned by insiders.

CME Group Trading Up 0.5%

• Gold, Silver, and Copper Are Surging—Here Are 3 Smart Ways to Play It

NASDAQ:CME opened at $275.54 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16. The firm has a market capitalization of $99.08 billion, a price-to-earnings ratio of 23.37, a price-to-earnings-growth ratio of 3.26 and a beta of 0.24. The stock has a fifty day simple moving average of $263.56 and a 200 day simple moving average of $277.42.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the previous year, the company earned $2.96 EPS. The business's revenue for the quarter was up .8% compared to the same quarter last year. Sell-side analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group's dividend payout ratio (DPR) is 44.11%.

CME Group Company Profile

(Free Report)

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.

The company's principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.

See Also

• Five stocks we like better than CME Group
• Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
• Optical Cable Corporation Is Starting to Get the Market’s Attention
• Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
• Is Nike's Index Demotion a Warning or a Buying Opportunity?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here